US EditionKimberly-Clark to Sell International Kleenex Business, Other Tissue Assets for $3.4 Billion
- Kimberly-Clark and Suzano announced on Thursday a $3.4 billion joint venture for global consumer and professional tissue businesses outside North America.
- The deal follows Kimberly-Clark's efforts to reorganize amid weak sales and tariff challenges, while Suzano pursues growth in scalable, cost-efficient businesses.
- Suzano will acquire a 51% stake by paying $1.7 billion cash, with Kimberly-Clark retaining 49% and contributing over 40 international brands and 22 manufacturing sites.
- Kimberly-Clark CFO Nelson Urdaneta noted $300 million in tariff costs this year, mainly from a 145% China duty, with plans to mitigate about a third of the impact in 2025.
- The joint venture, based in the Netherlands and expected to close mid-2026, supports Kimberly-Clark's strategy to boost profitability and growth, especially in personal care and North America.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
All
Left
3
Center
6
Right
1
2 Dividend Kings Reshaping Their Empires—Here's The Hidden Opportunity
Key Points in This Article: Dividend Kings like Kimberly-Clark (KMB) and Procter & Gamble (PG) demonstrate financial resilience by increasing dividends for over 50 years, with recent restructurings aimed at enhancing profitability. Kimberly-Clark’s $3.5 billion Kleenex sale and Procter & Gamble’s plan to cut 7,000 jobs and divest non-core brands focus on streamlining operations for higher margins. These restructurings present investors with p…
·New York, United States
Read Full Article
Coverage Details
Total News Sources17
Leaning Left3Leaning Right1Center6Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 30%
C 60%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
